Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Epidemiological studies have observed a positive association between an earlier age at sexual development and prostate cancer, but markers of sexual maturation in boys are imprecise and observational estimates are likely to suffer from a degree of uncontrolled confounding. To obtain causal estimates, we examined the role of pubertal development in prostate cancer using genetic polymorphisms associated with Tanner stage in adolescent boys in a Mendelian randomization (MR) approach.We derived a weighted genetic risk score for pubertal development, combining 13 SNPs associated with male Tanner stage. A higher score indicated a later puberty onset. We examined the association of this score with prostate cancer risk, stage and grade in the UK-based ProtecT case-control study (n = 2,927), and used the PRACTICAL consortium (n = 43,737) as a replication sample.In ProtecT, the puberty genetic score was inversely associated with prostate cancer grade (odds ratio (OR) of high- vs. low-grade cancer, per tertile of the score: 0.76; 95 % CI, 0.64-0.89). In an instrumental variable estimation of the causal OR, later physical development in adolescence (equivalent to a difference of one Tanner stage between pubertal boys of the same age) was associated with a 77 % (95 % CI, 43-91 %) reduced odds of high Gleason prostate cancer. In PRACTICAL, the puberty genetic score was associated with prostate cancer stage (OR of advanced vs. localized cancer, per tertile: 0.95; 95 % CI, 0.91-1.00) and prostate cancer-specific mortality (hazard ratio amongst cases, per tertile: 0.94; 95 % CI, 0.90-0.98), but not with disease grade.Older age at sexual maturation is causally linked to a reduced risk of later prostate cancer, especially aggressive disease.

Original publication

DOI

10.1186/s12916-016-0602-x

Type

Journal article

Journal

BMC medicine

Publication Date

04/04/2016

Volume

14

Pages

66 - 66

Addresses

MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.

Keywords

PRACTICAL consortium, Humans, Prostatic Neoplasms, Neoplasm Staging, Odds Ratio, Risk Factors, Regression Analysis, Survival Analysis, Case-Control Studies, Random Allocation, Age of Onset, Puberty, Sexual Maturation, Polymorphism, Single Nucleotide, Adolescent, Aged, Middle Aged, Male, Genome-Wide Association Study, Mendelian Randomization Analysis, United Kingdom